Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Colorectal Neoplasms 161Squamous Cell Carcinoma of Head and Neck 95Head and Neck Neoplasms 95Colonic Neoplasms 46Rectal Neoplasms 39Neoplasm Metastasis 35Carcinoma, Non-Small-Cell Lung 29Carcinoma, Squamous Cell 25Pancreatic Neoplasms 18Neoplasms 18Esophageal Neoplasms 18Lung Neoplasms 17Stomach Neoplasms 13Laryngeal Neoplasms 12Recurrence 11Oropharyngeal Neoplasms 11Mouth Neoplasms 11Esophageal Squamous Cell Carcinoma 11Colorectal Cancer Metastatic 10Tongue Neoplasms 9Carcinoma 9Breast Neoplasms 9Nasopharyngeal Carcinoma 8Hypopharyngeal Neoplasms 8Adenocarcinoma Of Esophagus 8Laryngeal Diseases 6Salivary Gland Neoplasms 5Neoplasms, Squamous Cell 5Glioblastoma 5Uterine Cervical Neoplasms 4

Interventions

Surveys and Questionnaires 1Radiotherapy 1Hydroxyurea 1Fluorouracil 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Nose Neoplasms × Cetuximab × Clear all
NCT00462735 2018-03-13

Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer

Icahn School of Medicine at Mount Sinai

Phase 2 Completed
33 enrolled 15 charts
Head & Neck

Head and Neck Neoplasms, Laryngeal Neoplasms, Nose Neoplasms, Paranasal Sinus Neoplasms, Pharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡